Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Cancers|April 2, 2020
NK and NKT Cell-Mediated Immune Surveillance against Hematological MalignanciesKanako Shimizu, Tomonori Iyoda, Satoru Yamasaki, et al.
Metallomics : Integrated Biometal Science|April 23, 2013
A coupling system of capillary gel electrophoresis with inductively coupled plasma-mass spectrometry for the determination of double stranded DNA fragmentsShin-ichiro Fujii, Kazumi Inagaki, Shin-ichi Miyashita, et al.
Journal for Immunotherapy of Cancer|July 3, 2023
Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8<sup>+</sup> T cells against tumorKanako Shimizu, Shogo Ueda, Masami Kawamura, et al.
Frontiers in Immunology|December 19, 2013
NKT cells as an ideal anti-tumor immunotherapeuticShin-Ichiro Fujii, Kanako Shimizu, Yoshitaka Okamoto, et al.
Anticancer Research|July 2, 2014
Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activationHiroshi Hasegawa, Kimihiro Yamashita, Dai Otubo, et al.
International Journal of Hematology|June 17, 2010
Human leukemic cells loaded with alpha-galactosylceramide (alpha-GalCer) activate murine NKT cells in situKanako Shimizu, Michihiro Hidaka, Kara Bickham, et al.
Communications Biology|May 3, 2019
Eomes transcription factor is required for the development and differentiation of invariant NKT cellsKanako Shimizu, Yusuke Sato, Masami Kawamura, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|February 14, 2014
Time-resolved ICP-MS measurement: a new method for elemental and multiparametric analysis of single cellsShin-ichi Miyashita, Alexander S Groombridge, Shin-ichiro Fujii, et al.
Nature Communications|March 29, 2020
Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunityWooseok Seo, Kanako Shimizu, Satoshi Kojo, et al.
Pageof 12